Patent details

EP2249765 Title: Dapsone to treat rosacea

Basic Information

Publication number:
EP2249765
PCT Application Number:
US2008002549
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087261293
PCT Publication Number:
WO2009108147
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Dapsone to treat rosacea
French Title of Invention:
Dapsone pour traiter la rosacée
German Title of Invention:
Dapson zur Behandlung von Rosacea
SPC Number:

Dates

Filing date:
27/02/2008
Grant date:
13/11/2019
EP Publication Date:
17/11/2010
PCT Publication Date:
03/09/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/11/2019
EP B1 Publication Date:
13/11/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/02/2020
Expiration date:
27/02/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/11/2019
 
 

Name:
ALLERGAN, INC.
Address:
2525 Dupont Drive, Irvine, CA 92612, United States (US)

Inventor

Name:
GARRETT, John Steven
Address:
United States (US)

Classification

IPC classification:
A61K 8/46; A61K 9/00; A61K 9/06; A61K 31/145; A61K 47/32; A61P 17/10; A61Q 19/00;

Publication

European Patent Bulletin

Issue number:
201946
Publication date:
13/11/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages